QMSMEDI QMS Medical Allied Services Q4 FY26 results (Jan–Mar 2026) and concall
QMS Medical Allied Services reported an 11% YoY revenue growth to INR172.9 crores for FY26, with EBITDA at INR25.9 crores and PAT at INR11.9 crores. The company is strategically shifting towards its services segment, which now constitutes 31% of revenue and is targeted to double in FY27. Profitability was impacted by significant, front-loaded investments in technology, infrastructure, and human capital for new patient support programs, leading to margin compression in FY26, though management expects recovery in FY27.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 7.5%, net profit down 79.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 33 | 39 | 42 | 42 | 41 +26% | 30 −25% | 39 −8% |
| EBITDA | 5 | 5 | 8 | 6 | 6 +15% | 4 −29% | 4 −44% |
| Net profit | 3 | 2 | 3 | 3 | 3 +1% | 1 −75% | 1 −79% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
